# Magnetic Bead-Guided Assembly of 3D Primary Human Islet Cells in Decellularized Pancreatic Scaffolds

**Authors:** Marluce da Cunha Mantovani, Ana Claudia Oliveira Carreira, Nilsa Regina Damaceno-Rodrigues, Elia Garcia Caldini, Mari Cleide Sogayar

PMC · DOI: 10.3390/cells15040317 · 2026-02-07

## TL;DR

This paper introduces a new method using magnetic beads to assemble 3D human islet cell clusters in decellularized pancreatic scaffolds, which could improve diabetes research and tissue engineering.

## Contribution

The novel contribution is a magnetic bead-guided protocol for rapid 3D culture of primary human islet cells in decellularized pancreatic scaffolds.

## Key findings

- 3D islet-like clusters formed in 18 hours using magnetic beads in decellularized pancreatic scaffolds.
- Smaller cell clusters attached faster to the bioscaffold and spread out compared to larger clusters.
- Cells in 3D cultures maintained insulin production and stable LDH levels, indicating viability and functionality.

## Abstract

Background: Three-dimensional (3D) cell cultures are increasingly recognized as effective models for studying diseases and developing cell therapies. In the endocrine pancreas field, organoids/spheroids derived from human islet cells enable advances in diabetes research, drug screening, and tissue engineering. While various 3D culture methods exist, approaches such as magnetic bead-assisted aggregation remain underexplored for endocrine pancreatic cells. Additionally, the use of biological scaffolds, especially those derived from decellularized pancreatic extracellular matrix, provides a biomimetic environment that promotes adhesion, proliferation, and functionality of pancreatic cells. This study presents a protocol for magnetic bead-guided 3D culture of human islet cells within decellularized pancreatic scaffolds. Methods: Human pancreas from adult brain-dead donors was harvested for both islets’ isolation processing and decellularization to generate an acellular pancreatic bioscaffold. Primary human pancreatic islets were first grown in two-dimensional adherent cultures, then enzymatically harvested from the surface and reassembled into three-dimensional clusters using different initial cell amounts (small clusters 0.5 × 104–1 × 104 and larger clusters 2.5 × 104–5 × 104 cells) and then placed within acellular pancreatic slices of different thickness, namely 50 and 90 μm. Optic microscopic examination, scanning electron microscopy analysis, and assessment of insulin and lactate dehydrogenase (LDH) levels were used to evaluate these 3D islet-like cluster cultures. Results: We report the establishment of 3D cultures derived from primary pancreatic islet cells using a magnetic approach in a remarkable 18 h period for the complete formation of 3D clusters. The small clusters (0.5 × 104–1 × 104 cells) exhibited a faster attachment to the acellular matrix, with cells visibly spreading outside the cluster interacting with the bioscaffold slice, when compared to the larger clusters (2.5 × 104–5 × 104 cells). These cells continued to produce insulin, and no statistically significant differences in LDH levels were found under these different conditions. Conclusions: Here, we demonstrate that a magnetic bead-based protocol can be successfully applied to endocrine pancreatic cells, enabling the rapid formation of compact, viable, and functional 3D structures. Despite limitations such as higher cost and prolonged retention of magnetic particles, the approach supports size-dependent interactions with decellularized pancreatic scaffolds. These findings are valuable for researchers designing experiments tailored to specific objectives and underscore the potential of this platform for advancing diabetes research and pancreatic tissue engineering.

## Linked entities

- **Proteins:** PIN (insulin precursor)
- **Diseases:** diabetes (MONDO:0005015)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** NEUROG3 (neurogenin 3) [NCBI Gene 50674] {aka Atoh5, Math4B, NGN-3, bHLHa7, ngn3}, PDX1 (pancreatic and duodenal homeobox 1) [NCBI Gene 3651] {aka GSF, IDX-1, IPF1, IUF1, MODY4, PAGEN1}, IAPP (islet amyloid polypeptide) [NCBI Gene 3375] {aka DAP, IAP}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}, GATA4 (GATA binding protein 4) [NCBI Gene 2626] {aka ASD2, TACHD, TOF, VSD1}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, NES (nestin) [NCBI Gene 10763] {aka Nbla00170}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, SLC2A2 (solute carrier family 2 member 2) [NCBI Gene 6514] {aka GLUT2}
- **Diseases:** inflammatory (MESH:D007249), pancreatic ductal adenocarcinoma (MESH:D021441), injury to (MESH:D014947), pancreatic cancer (MESH:D010190), diabetes (MESH:D003920), pancreatic disorders (MESH:D010195), cystic fibrosis (MESH:D003550), pancreatic epithelial carcinoma (MESH:D009375), SAH (MESH:D013345), brain (MESH:D001927), Cytotoxicity (MESH:D064420)
- **Chemicals:** copper (MESH:D003300), iron oxide (MESH:C000499), Dithizone (MESH:D004230), ethanol (MESH:D000431), PBSA (MESH:C437084), gold (MESH:D006046), SDC (MESH:D003840), paraffin (MESH:D010232), osmium tetroxide (MESH:D009993), fluorescein diacetate (MESH:C018506), PI (MESH:D010716), xylene (MESH:D014992), Triton X-100 (MESH:D017830), ciprofloxacin (MESH:D002939), L-glutamine (MESH:D005973), CO2 (MESH:D002245), agarose (MESH:D012685), PFA (MESH:C003043), glutaraldehyde (MESH:D005976), eosin (MESH:D004801), glucose (MESH:D005947), H&amp;E (MESH:D006371), Acellular (-), propidium iodide (MESH:D011419), Hematoxylin (MESH:D006416)
- **Species:** Mycoplasma (genus) [taxon 2093], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PANC-1 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0480)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939310/full.md

---
Source: https://tomesphere.com/paper/PMC12939310